‘make It Happen:’ How Donors Wielded Influence On A Prestigious Medical School
NEW YORK — The money came with strings attached.
As a condition of a $12.5 million donation, Mount Sinai’s Icahn School of Medicine in Manhattan agreed to christen a global health center after its benefactors: the Arnhold banking family.
The charity director facilitating the Arnholds’ gift also had a suggestion: Would Mount Sinai — one of the country’s most prestigious medical schools — consider tapping an impressive friend of his as the institute’s leader?
He was a 32-year-old academic and trainee doctor named Prabhjot Singh. At that time, in 2014, Singh was just wrapping up his medical training at Mount Sinai Hospital after a post-doctoral fellowship at Columbia University. He had scant global health research to his name. But he got the job.
The decision complicated Mount Sinai’s standard hiring process, which had already yielded a list of more experienced candidates, according to thousands of recently released pages of deposition transcripts, emails and other records reviewed by POLITICO. When Singh later faced accusations that he mistreated employees — which he denies — the Arnholds and their charity director sought to intervene to protect him, the records show. The Arnholds even said they would donate more money to the medical school, after the dean suggested it would “go a long way toward smoothing the waters,” according to contemporaneous emails about the conversation.

Singh resigned from his leadership role in 2019, not long after eight current and former Arnhold Institute employees filed a federal lawsuit accusing him of age and gender discrimination and seeking financial damages. Their complaint raised Singh’s hiring process as part of a pattern of “double standards, sexism and ageism that pervade this case.”
“Singh’s victims got no second chances: they were forced out or fired, their previously stellar careers in tatters, some needing to see counsellors and take antidepressants and anti-anxiety medications to deal with the stress and humiliation he heaped on them,” the employees’ amended complaint alleged. “They did nothing wrong, continue to suffer, and have received no apology or redress.”
Seven years later, their case is still pending. The discovery process has meanwhile revealed an extraordinarily candid picture of the role of outside influences on decisionmaking within the upper echelons of Mount Sinai — offering a rare window into the workings of a private, nonprofit institution.
Mount Sinai declined to answer a detailed list of questions or comment on any of the public records referenced in this story, citing the pending litigation. Singh did not respond to emails requesting comment, nor did his lawyers, who are also representing Mount Sinai in the ongoing lawsuit. Their legal team has argued the employees presented no evidence that Singh created a hostile work environment or treated them differently due to their age or gender. They also argued Singh acted in good faith and complied with Mount Sinai’s anti-discrimination policies. In a June court filing, the lawyers described the employees’ anecdotes as “trivial inconveniences” and “petty slights.”
Academic medical centers like Mount Sinai — hybrid institutions that run hospitals, confer medical degrees and conduct research — have long appealed to wealthy and grateful patients eager to splash their name on a building or endow a faculty position. The address of Mount Sinai’s flagship hospital in Manhattan bears the name of the late Goldman Sachs executive Gustave Levy, a longtime trustee and former board chairman. Its medical school is named after billionaire investor Carl Icahn. Mount Sinai drew criticism earlier this year after Justice Department records revealed the special treatment afforded to the late convicted sex offender, Jeffrey Epstein, who repeatedly donated to the institution in the years after his 2008 conviction on state charges of soliciting a minor for prostitution. (Mount Sinai responded by calling Epstein’s actions “abhorrent” and said it’s reviewing the files and taking appropriate actions.)
Now that large appetite for philanthropy is growing ravenous, as academic medical centers face a trifecta of political threats to their tax exemptions, research grants and reimbursement rates. Mount Sinai is especially vulnerable to those headwinds as one of the nation's top recipients of National Institutes of Health funding, and it has already landed in the crosshairs of the Justice Department and Federal Trade Commission for its provision of gender-affirming care to minors.
Health systems’ total fundraising revenue has “risen sharply” in the last several years, a 2025 survey by the Association for Healthcare Philanthropy found. Alice Ayres, the association’s president and CEO, said the financial hit of the COVID-19 pandemic — and now President Donald Trump’s One Big Beautiful Bill Act — pushed health care executives to treat philanthropy as a “strategic imperative,” not just a nice revenue cushion to have.
New York City’s academic medical centers, whose boards are stacked with billionaire real estate and finance moguls, are better positioned than most to weather the storm. Mount Sinai drew accolades from credit analysts this year for its “exceptional fundraising,” including a campaign that topped $2 billion, and a recent job posting says its gift-planning program is growing.

But Betsy Chapin Taylor, a health care philanthropy consultant, said the pool of major donors has been shrinking, while the size of their gifts is growing. (About 9% of overall charitable giving in the U.S. — or roughly $61 billion — went to health care organizations last year, according to Indiana University research.) As a result, the biggest donors have the potential to wield even greater influence.
“The legal and moral obligation falls on the health system right now to use the dollars effectively,” she said in an interview. “It’s not the influence itself that is the problem. It is the governance of the organization that decides what boundaries there are.”
State Sen. Liz Krueger, a former nonprofit executive who chairs the powerful Senate Finance Committee, said charitable institutions like Mount Sinai should use gifts to advance their mission. As things stand, nonprofits’ boards face minimal oversight.
“I’m always a fan of more transparency,” Krueger said, “so that people know exactly how money is being received and spent.”
A ‘high-risk’ hire
Singh wasn’t the first choice.
When John and Jody Arnhold’s $12.5 million gift was announced in April 2014, Mount Sinai was still looking for the perfect person to take charge of the institute that would bear their name.
The couple had donated $3 million to Mount Sinai over the years, emails and court records show. Their generosity reflected their fondness for the family’s pediatrician, Ramon Murphy, an impassioned global health advocate who had worked at Mount Sinai for decades. (Murphy died in 2019.)

Mount Sinai pitched John Arnhold on a $25 million gift to get the global health institute up and running, according to an email thread shared with POLITICO by a former employee who participated in the discussion. Arnhold, an investment adviser, instead suggested a $12.5 million pledge that Mount Sinai would match with its own budget, the emails show.
Yet Murphy, as he recounted in a recorded phone call with a former Arnhold Institute employee several years later, got the impression more money wasn’t out of the question. Kevin Starr — a longtime friend of the Arnhold family who helps manage their philanthropic giving — suggested he could coax the couple to donate an even greater sum if the institute brought on a friend of his, Murphy said in the 2018 recording. The recording was shared with POLITICO by the employee, Natasha Anushri Anandaraja, who is involved in litigation against Mount Sinai.
The friend was Singh.

Mount Sinai’s internal search committee already favored Steffanie Strathdee, an experienced global health scholar at University of California San Diego known for her work on HIV prevention, court records show. Her resume was flush with hundreds of peer-reviewed papers. Perhaps even more importantly, Strathdee had a track record of successfully securing federal research grants. A revenue flow like that would be crucial to the institute’s longevity.
The possibility fell apart after Mount Sinai rebuffed Strathdee’s budget proposal, according to court records. She withdrew from consideration in October 2014.
The job opening had already yielded a 10-person shortlist of experienced global health scholars, according to court records. Singh hadn’t even applied yet, Mount Sinai later acknowledged in a court filing. But Starr said he encouraged Singh to pursue the job, then “persuaded” his friend to take it, according to deposition excerpts and emails. Starr had befriended Singh roughly three years earlier at a science and technology conference and was “very impressed with the way he thought,” he said in his deposition, which POLITICO reviewed.
Starr thought it important that the new institute have a “particular point of view, a particular vision” that would make it “stand out” from other global health programs across the country, he said in the deposition. Singh had a “certain eggheaded charisma,” as Starr described him in an email years later, and could help make the new institute “highly distinctive and influential.”
Contrary to Starr’s characterization, Singh didn’t seem to need much convincing.
“I think it would be useful for me to have some sort of role for the institute,” Singh had told Starr in an email many months earlier, after his friend revealed the forthcoming $12.5 million donation to Mount Sinai. “My sense is that if you told the chair of the medicine dept … that it was a condition of the grant, she would be very supportive.”

Starr’s email back to Singh did not address the suggested “condition.” The issue came up again when Anandaraja, the former Arnhold Institute employee, later alleged in a state lawsuit that Starr told her “he would be able to convince the Arnholds to donate $15 million more if Singh became AIGH’s Director.”
Starr has repeatedly denied that any money was contingent on Singh being hired, whether the Arnholds’ initial $12.5 million or a later $15 million gift, including in a deposition as part of the federal lawsuit and in a recent phone interview.
“I did not make it a condition of the grant, and I wasn’t in any position to do so, in any case,” Starr told POLITICO.
The search committee was lukewarm on Singh’s application. Singh was “not as strong a candidate” as Strathdee, their first choice, one committee member said in a deposition. Singh struck them as extremely intelligent, but he had limited leadership experience and no record of securing federal grants — two of the listing’s key criteria. He had hardly any peer-reviewed global health papers on his resume. And Singh was still wrapping up his medical residency at Mount Sinai at the time, following a postdoctoral fellowship at Columbia University with world-famous economist Jeffrey Sachs.
That same committee member ended up offering a “very heavily caveated endorsement” of Singh, calling him a “high-risk candidate with potentially high reward” in his deposition.
Luckily for Singh, his application came with yet another sweetener: his postdoc adviser, Sachs, promised to mentor him.
“[Sachs] was clear that he did not want him to fail and would not recommend him for something he was not ready for and therefore something that he would fail at, as this would be unfair to Prabhjot and a loss of a talented person,” a Mount Sinai official wrote in a December 2014 email. "He [Sachs] said, despite the fact that he is very busy he would be happy to help mentor him, for 2 reasons; (1) he wants Prabhjot to succeed and (2) because of Jeffrey's own support of Mount Sinai and the importance of what we are trying to do."
Mount Sinai had offered Strathdee — the search committee’s top pick — a $6 million package to get the Armhold Institute up and running, but she said that would be insufficient to “grow a stellar program without cutting beyond the bone,” emails show.
Singh received a start-up package of just $4.5 million, according to his offer letter. As part of the hire, Mount Sinai officials pitched an internal oversight committee to guide Singh. But the committee would not be entirely internal: It would also include Singh’s postdoc adviser, Sachs, who didn’t work for Mount Sinai — at least, not yet. (It is unclear if the committee ever materialized.)
“Given Prabhjot's youth and relative inexperience with academic leadership, we both feel that this will be essential for at least the first 1-3 years of Prabhjot's tenure,” one official wrote in a January 2015 email, adding, “with guidance we can reduce likelihood of failure and maximize the chances for his and the lnstitute's success.”
It helped that Dennis Charney, the dean of Mount Sinai’s medical school at the time, considered Singh a “remarkable find,” as he said in court filings. Charney, too, had suggested that Singh apply, Singh later said in a deposition.
One month later, Charney announced Singh had been hired.

Years later, Mount Sinai’s HR leadership allegedly pressed Charney to pay more heed to their hiring protocol, according to a second discrimination complaint filed in state court by four former Arnhold Institute employees who were dismissed from the first case, including Anandaraja. (A judge said two of the employees’ claims were time-barred and the other two had failed to sufficiently plead their claims.) Charney, who is named in both discrimination lawsuits and retired as dean last year, and his lawyers did not respond to requests for comment; he has denied the plaintiffs’ claims.
Strathdee declined to discuss her experience with Mount Sinai’s hiring process, but she said the decision to form an oversight committee struck her as highly unusual.
“I’ve never heard of anything like that before,” Strathdee told POLITICO.
‘Sparks of Brilliance’
The solution was simple.
A mere cellphone could help people around the world live longer, Singh said in a 2013 presentation he titled “Sparks of Brilliance.” Singh had come to that conclusion after working in sub-Saharan Africa, he told attendees at that year’s PopTech conference, an annual confab billed as “one of the longest-running thought forums in the U.S.” The key was equipping people with the information they needed to take control of their health.
Two years later, as the inaugural director of the Arnhold Institute for Global Health, Singh was in a prime position to turn his vision into reality. He would call it Atlas.
Singh’s first day on the job was in September 2015 and, luckily for him, the Arnhold Institute was about to receive a fresh influx of cash. The Arnholds donated an additional $15 million that December to support Singh’s strategic plan, according to a copy of the grant agreement reviewed by POLITICO.
Singh would also get another chance to work together with Sachs, his longtime mentor. Sachs joined Mount Sinai in 2016 for a two-year visiting fellowship to “provide insights” from his international economic development work and conduct seminars. He earned an annual salary of $121,100 for roughly eight hours of work each week, former Arnhold Institute employees later alleged in court filings. (Sachs did not respond to requests for comment, and Mount Sinai would neither confirm nor deny the salary figure.)
The Arnholds had wanted their money for the global health institute to primarily support training and education, according to a 2013 email thread between fundraisers for Mount Sinai that POLITICO reviewed. But Singh complained about the institute’s “educational component” and instead favored “flashy” and “innovative” solutions that would “increase his visibility,” a former employee said in a sworn declaration.
In short order, Atlas became Singh’s signature project.
One problem with Atlas was hardly anyone seemed to get what it was. Starr, who periodically touched base with Singh as the Arnholds’ go-between, later said in a deposition that Atlas seemed to be a “big focus” but that he “never really fully understood how the technology would work or how it would be applied.”
The basic pitch was a system to identify patients in remote areas who likely needed medical assistance. By using artificial intelligence to interpret satellite imagery and other data, the goal was to eventually cut response times to brewing public health crises from “four weeks to four minutes,” as Singh put it.
The Arnhold Institute started building a prototype as part of a one-year pilot in Guatemala funded by the U.S. Agency for International Development in 2016. Theoretically, community health workers would access Atlas on mobile devices to identify pregnant women who should be tested for Zika, a disease transmitted by mosquitoes that can cause birth defects. Without access to vast amounts of data, however, Atlas had no way to identify those people.
Singh touted Atlas as a 2017 panelist at the prestigious Aspen Ideas Festival, which Mount Sinai has long underwritten. The Arnhold Institute would soon test the system in Sierra Leone, Singh said on stage.
But by the pilot’s end later that year, Atlas was still an “unfinished prototype," one of its product managers, who later joined the Arnhold Institute lawsuit, said in a sworn declaration. Yet the institute’s final report to USAID suggested there were “a total of 224 Atlas core users” across dozens of districts in Guatemala, including nurses and epidemiologists. An employee who worked on Atlas later flagged the number in a whistleblower complaint to USAID, which alleged “there were zero core users” and “what Singh stated to USAID was false,” according to a report obtained by POLITICO through a public records request. (USAID’s Office of Inspector General declined to investigate and referred the complaint to USAID’s mission director in Guatemala, who didn’t return a request for comment.)

During an interview about the Arnhold Institute’s initiatives at the Aspen Ideas Festival the following year, in July 2018, Singh didn’t mention Atlas once. Singh had just hired a dedicated director for Atlas a couple months earlier, but the project was shelved sometime after that, court records show. The would-be Atlas director offered little explanation in a later deposition.
“We didn’t move forward with it,” he said in the deposition. “The software environment had changed.”
‘A slap on the wrist’
By the time the Arnhold Institute closed the book on its Atlas pilot, staff complaints and resignations were piling up.
Mount Sinai launched an internal investigation into Singh’s leadership in spring 2018, following a complaint by two employees — both women — that he had discriminated against them, according to court records. After interviewing more than a dozen current and former employees of the institute, Mount Sinai found no evidence of discrimination by Singh.
But Starr, the one overseeing the Arnholds’ multimillion-dollar gifts, was worried that the probe would discourage Singh.
“It’s mostly a slap on the wrist, but it will go into his official HR file, something that really pisses him off,” Starr wrote in a four-page email to John Arnhold in June 2018. Starr worried Mount Sinai’s “letter of reproach” would push Singh to leave, he wrote in a subsequent email.
Singh had already said as much. His goal, as he described it in an email to Starr, was to “get out of this current mess without any formal disciplinary action,” so that “hopefully somehow staying at Arnhold begins to feel viable.”

Singh also suggested that Starr, when speaking with Mount Sinai, “hold any $ discussion as highly contingent on how things proceed vis a vis my ability/institute to flourish (not simply survive),” according to the email. The former employees’ lawsuit claims Starr “clearly tied a proposed future $50 million donation to [the Arnhold Institute] to Singh’s continued employment as director,” although it cites no source.
The Arnholds, who did not respond to requests for comment, eventually took matters into their own hands. They met with Charney, the powerful dean of Mount Sinai’s medical school, who “vowed his support” for Singh, as John Arnhold recounted in an email afterwards. But the dean, like his generous benefactors, wanted something in return for his support.
“Jody and I told him that we expect his strong advocacy for Prabhjot,” John Arnhold wrote in a July 2018 email describing the meeting with Charney. “He agreed that, if Prabhjot met his goals, the letter should explode into thin air. He asked whether a small amount of money (100-200 thousand) could be redirected to teaching program [sic]. Said it would go a long way toward smoothing the waters. I said yes.”
John Arnhold’s wife, Jody, summed up the arrangement in her own email to Starr: “Yes — money for medical education and as a gesture of good will and a small token of apology — take the letter/note out of the file.” Jody Arnhold wanted the letter about the internal investigation out of Singh’s HR file immediately, she instructed Starr in another email. It’s unclear if that ever happened.
“You are the front man Kevin,” Jody Arnhold wrote to Starr in August 2018. “Make it happen.”

Asked to comment on the exchange, Starr said he considered it unfair to have an unfounded complaint on Singh’s record and that the request appeared benign.
“I don’t think there’s anything sinister there at all,” Starr told POLITICO. “This is not an example of donors reaching into the sausage works and playing with the machinery.”
‘See no evil’
The tensions smoldering inside the Arnhold Institute burst into flames one year later, when eight current and former employees filed a federal discrimination lawsuit against Singh and Mount Sinai. Their claims made national news.
The employees accused Singh of excluding them from projects, in favor of new hires who were younger or male. They claimed Singh assigned them to administrative tasks below their paygrade, while dismissing their work as “subpar and unworthy of his attention” and denying them credit for their accomplishments. He talked about bringing in “younger” employees. The result, they argued, was Singh and two of his male deputies created a hostile work environment.
They also described an institutional culture of “see no evil” pervading Mount Sinai — a pattern of senior officials failing to take action when faced with complaints of wrongdoing.
“The culture that allowed Singh to thrive was set at the top,” they alleged in an amended version of their complaint filed in August 2019, noting Charney’s role in hiring Singh.
In response, more than 400 faculty and staff at Mount Sinai’s medical school signed a petition to the board of trustees demanding an investigation. The co-chairs of the board agreed to form a special committee to review the issue.

A couple months later, in July 2019, the medical school announced Singh was stepping down as director of the Arnhold Institute, though he would remain on Mount Sinai’s faculty. Mount Sinai declined to answer questions about the status of Singh’s faculty employment or the Arnholds’ request to remove the internal investigation from his personnel file. Mount Sinai, Singh, Charney and the other defendants have denied the claims in court records.
“Mount Sinai deserves credit for the lives it saves every day, but it is also a big-money, powerful New York institution that exists in a web of trading favors and pleasing donors,” Ann Olivarius, a lawyer for the employees suing Singh and Mount Sinai, said in a statement to POLITICO. “Singh upended the careers of our clients and could not deliver on his promises, or perform competently in his job, but the hurt and professional destruction he caused did not matter to leaders of Sinai compared to pleasing the powerful.”
The discrimination case could soon head to trial, following seven years of legal squabbles. The companion lawsuit, filed in state court by four former Arnhold Institute employees after they were dismissed from the federal case, remains in discovery. The litigation has forced a vast amount of information to light, but the conclusions of the board’s special committee review remain a secret, according to the plaintiffs’ lawyers. Mount Sinai declined to comment on the committee’s findings or share a copy of any written report.

Singh spent the intervening years in the startup space, most recently founding an AI company called Altitude that analyzes patient records and recommends clinical decisions to their health care providers. He also works as a paid adviser to the Peterson Center on Healthcare, a grantmaking organization established by the late commerce secretary’s namesake foundation to find innovative solutions to transform the U.S. health care system.
All the while, the Arnholds kept giving to Mount Sinai. The Arnhold Institute, now under the leadership of the HIV researcher and pediatrician Rachel Vreeman, received another major windfall from its founding family in 2023. It was $8 million.
Popular Products
-
Classic Oversized Teddy Bear$23.78 -
Gem's Ballet Natural Garnet Gemstone ...$171.56$85.78 -
Butt Lifting Body Shaper Shorts$95.56$47.78 -
Slimming Waist Trainer & Thigh Trimmer$67.56$33.78 -
Realistic Fake Poop Prank Toys$99.56$49.78